Nitric oxide-releasing phosphodiesterase type 5 inhibitor

摘要

Nitric Oxide-Releasing Phosphodiesterase Type 5 Inhibitor The present invention is useful in treating ocular conditions associated with elevated intraocular pressure, such as ocular hypertension, glaucoma or retinopathy, according to formula (I) or (Ib) or ( II), a nitric oxide-releasing phosphodiesterase type 5 (PDE5) inhibitor, or a steric isomer thereof or a pharmaceutically acceptable salt thereof. The present invention further relates to 3-[(2S) -2,3-bis (nitrooxy) propoxy] for use in the treatment of ocular conditions associated with elevated intraocular pressure, such as ocular hypertension, glaucoma or retinopathy. With respect to propanoic acid and 6- (nitrooxy) hexanoic acid.